Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival.
All natural Leishmania infections start in the skin; however, little is known of the contribution made by the sand fly vector to the earliest events in mammalian infection, especially in inflamed skin that can rapidly kill invading parasites. During transmission sand flies regurgitate a proteophosphoglycan gel synthesized by the parasites inside the fly midgut, termed promastigote secretory gel (PSG). Regurgitated PSG can exacerbate cutaneous leishmaniasis. Here, we show that the amount of Leishmania mexicana PSG regurgitated by Lutzomyia longipalpis sand flies is proportional to the size of its original midgut infection and the number of parasites transmitted. Furthermore, PSG could exacerbate cutaneous L. mexicana infection for a wide range of doses (10-10,000 parasites) and enhance infection by as early as 48 hours in inflamed dermal air pouches. This early exacerbation was attributed to two fundamental properties of PSG: Firstly, PSG powerfully recruited macrophages to the dermal site of infection within 24 hours. Secondly, PSG enhanced alternative activation and arginase activity of host macrophages, thereby increasing L-arginine catabolism and the synthesis of polyamines essential for intracellular parasite growth. The increase in arginase activity promoted the intracellular growth of L. mexicana within classically activated macrophages, and inhibition of macrophage arginase completely ablated the early exacerbatory properties of PSG in vitro and in vivo. Thus, PSG is an essential component of the infectious sand fly bite for the early establishment of Leishmania in skin, which should be considered when designing and screening therapies against leishmaniasis.
Rogers
Matthew
M
Department of Immunology, Imperial College of Science, Technology and Medicine, London, UK. matthew.rogers@imperial.ac.uk
Kropf
Pascale
P
Choi
Beak-San
BS
Dillon
Rod
R
Podinovskaia
Maria
M
Bates
Paul
P
Müller
Ingrid
I
D000818:Animals; D001119:Arginase / Q000378:metabolism; D004195:Disease Models, Animal; D005260:Female; D054884:Host-Pathogen Interactions; D007303:Insect Vectors / Q000378:metabolism / Q000469:parasitology; D057045:Laryngopharyngeal Reflux / Q000469:parasitology*; D007894:Leishmania mexicana / Q000254:growth & development / Q000378:metabolism / Q000472:pathogenicity / Q000502:physiology*; D016773:Leishmaniasis, Cutaneous / Q000469:parasitology*; D008264:Macrophages / Q000378:metabolism*; D008565:Membrane Proteins / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D011509:Proteoglycans / Q000378:metabolism*; D015800:Protozoan Proteins / Q000378:metabolism*; D011576:Psychodidae / Q000378:metabolism / Q000469:parasitology*
D008565:Membrane Proteins; C400527:Ppg1 protein, Leishmania; D011509:Proteoglycans; D015800:Protozoan Proteins; D001119:Arginase
FASEB J. 2005 Jun;19(8):1000-2
15811879
FEBS Lett. 2003 Sep 25;552(2-3):110-4
14527670
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10125-30
18626016
Nat Rev Immunol. 2003 Jan;3(1):23-35
12511873
Eur J Cell Biol. 1999 Oct;78(10):675-89
10569240
Annu Rev Microbiol. 2001;55:453-83
11544364
J Exp Med. 1998 Nov 16;188(10):1941-53
9815271
J Surg Res. 2002 Jun 1;105(1):35-42
12069499
Exp Parasitol. 1963 Aug;14:92-106
14053108
J Clin Invest. 2005 Jan;115(1):56-65
15630444
Nature. 1995 Jun 1;375(6530):408-11
7539113
Cell Microbiol. 2008 Jun;10(6):1363-72
18284631
PLoS Negl Trop Dis. 2008 May 14;2(5):e235
18478052
Nat Immunol. 2001 Oct;2(10):907-16
11577346
Infect Immun. 2004 Mar;72(3):1240-7
14977924
PLoS Pathog. 2007 Jun;3(6):e91
17604451
Nat Rev Immunol. 2007 Dec;7(12):975-87
18007680
Clin Infect Dis. 2000 Jul;31(1):199-201
10913426
PLoS Negl Trop Dis. 2008 Sep 17;2(9):e294
18820742
Parasite Immunol. 2002 Mar;24(3):113-8
11982856
J Immunol. 1998 Nov 15;161(10):5571-7
9820534
Infect Immun. 2004 Apr;72(4):1920-8
15039311
J Surg Res. 1993 Jul;55(1):97-102
8105150
Science. 2000 Nov 17;290(5495):1351-4
11082061
Med Microbiol Immunol. 1997 Oct;186(2-3):75-81
9403834
Nature. 2004 Jul 22;430(6998):463-7
15269771
Immunobiology. 2007;212(9-10):795-812
18086380
J Immunol. 2003 Nov 1;171(9):4561-8
14568929
Am J Physiol. 1997 Feb;272(2 Pt 1):E181-90
9124321
J Immunol. 2007 Sep 15;179(6):3926-36
17785830
Am J Trop Med Hyg. 1985 Mar;34(2):278-82
3985271
J Biol Chem. 2001 Feb 16;276(7):4988-97
11071892
PLoS Negl Trop Dis. 2008 Apr 16;2(4):e226
18414648
Science. 2008 Aug 15;321(5891):970-4
18703742
J Immunol. 2001 Nov 1;167(9):5226-30
11673536
J Immunol. 1995 Oct 1;155(7):3501-6
7561045
Int J Parasitol. 2007 Aug;37(10):1097-106
17517415
Exp Parasitol. 1993 Jun;76(4):412-23
8513879
Am J Trop Med Hyg. 2007 Jan;76(1):88-94
17255235
J Parasitol. 1994 Feb;80(1):93-9
8308664
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15551-6
16223880
J Exp Med. 1996 Apr 1;183(4):1501-14
8666908
Infect Immun. 2002 Oct;70(10):5512-20
12228277
Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7845-50
18509051
Immunol Rev. 2006 Oct;213:159-79
16972903
J Immunol. 2004 Dec 1;173(11):6521-5
15557140
J Immunol. 2005 Dec 15;175(12):8346-53
16339576
Science. 1988 Mar 11;239(4845):1306-8
3344436
Eur J Immunol. 1995 Apr;25(4):1101-4
7537672
Nat Immunol. 2008 Dec;9(12):1399-406
18978793
Nat Rev Immunol. 2004 Aug;4(8):583-94
15286725
BMC Immunol. 2002 Jul 04;3:7
12098359
Parasitology. 2002 May;124(Pt 5):495-507
12049412